MMDA-3b
Pharmaceutical compound
From Wikipedia, the free encyclopedia
MMDA-3b, also known as 4-methoxy-2,3-methylenedioxyamphetamine (4-MeO-2,3-MDA), is a psychedelic drug of the phenethylamine, amphetamine, and MDxx families related to ORTHO-MDA (2,3-MDA).[2][1] It is the 4-methoxy derivative of ORTHO-MDA and is a positional isomer of MMDA (5-MeO-3,4-MDA) and related compounds like MMDA-2 (6-MeO-3,4-MDA) and MMDA-3a (2-MeO-3,4-MDA).[1]
- None
| Clinical data | |
|---|---|
| Other names | 4-MeO-2,3-MDA; 4-Methoxy-2,3-methylenedioxyamphetamine; 2,3-Methylenedioxy-4-methoxyamphetamine; 4-Methoxy-ORTHO-MDA; 4-MeO-ORTHO-MDA |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic; Hallucinogen; Serotonin releasing agent |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | Unknown[1] |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C11H15NO3 |
| Molar mass | 209.245 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
MMDA-3b was included as an entry in Alexander Shulgin's book PiHKAL (Phenethylamines I Have Known and Loved).[1] He lists its dose as greater than 80 mg orally and its duration as unknown.[1][3] Shulgin describes 60 mg as being definitely active, qualitatively like 3,4-methylenedioxyamphetamine (MDA), but quantitatively perhaps less, whereas an 80 mg dose of MMDA-3b was said to be no more effective than the 60 mg dose.[1] He also says that it is similar at these doses to 20 mg MMDA-3a and may be about 3-fold less potent than MMDA-3a.[1] Elsewhere, MMDA-3b is described as 3-fold more potent than mescaline.[4]
MMDA-3b has been found to act as an efficacious serotonin releasing agent with little effect on dopamine similarly to MMDA.[5] For comparison, MDA and MDMA release both serotonin and dopamine, whereas MMDA-2 releases neither serotonin nor dopamine.[5]
The chemical synthesis of MMDA-3b has been described.[1] Other 2,3-MDA positional isomers of MMDA-3b include MMDA-4 and MMDA-5.[2][1]
MMDA-3b was first described in the scientific literature by Shulgin in 1964.[6] It was subsequently described in greater detail by Shulgin in his book PiHKAL in 1991.[1] The drug is a controlled substance in Canada under phenethylamine blanket-ban language.[7]